 |
 |
New Venture Partners LLC is a leading investor in spin-outs from the corporate sector and with a track record for producing innovative product-driven spin-out companies.
Execute was asked to provide technical and commercial due diligence and business planning services to support the decision to support the investment in a new company that would develop massively-parallel biosensor arrays for application in proteomics and drug discovery research.
This work is ongoing. |
| |
